Specific targeting of IL-6 signalling pathway: a new way to treat IBD?

Post-surgical recurrence of Crohn's disease: Situational analysis and future prospects.

Journal of visceral surgery·2021

The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases.

Mucosal immunology·2018

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

The American journal of gastroenterology·2017

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.

Digestive diseases and sciences·2016

Toxicological consequences of experimental exposure to aluminum in human intestinal epithelial cells.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2016

Gut: An underestimated target organ for Aluminum.

Morphologie : bulletin de l'Association des anatomistes·2016

Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs.

Gut·2026

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC.

Gut·2026

High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium.

Gut·2026

A durably colonising engineered native symbiont enables sustained intestinal delivery for metabolic dysfunction and colitis.

Gut·2026

Impact of non-enteric-coated pancreatic enzyme replacement therapy (NEPERT) on pain in patients with chronic pancreatitis: a double-blind, parallel-group, placebo-controlled, randomised trial.

Gut·2026

HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infection.

Gut·2026

Integrated Traditional Chinese and Western Medicine for Severe Tislelizumab-Induced Rash: A Case Report.

Case reports in oncology·2026

Glucocorticoids combined with rituximab treatment for IgG4-related tubulointerstitial nephritis with diabetic nephropathy: a case report.

Open medicine (Warsaw, Poland)·2026

Quality Assessment of an Immunotherapy Toxicity Clinic: A Clinical Audit at Castle Hill Hospital Evaluating Adherence to Clinical Guidelines, Documentation Standards, and Clinical Outcomes.

Cureus·2026

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

Human pathology·2026

CD20 targeted nanomedicine enhances anti-tumor immunity in diffuse large B-cell lymphoma by activating cGAS/STING pathway.

Cancer letters·2026

Effects of anion excipients on the viscosity of high-concentration mAb solution.

Journal of pharmaceutical sciences·2026

Related Experiment Videos

Specific targeting of IL-6 signalling pathway: a new way to treat IBD?

Related Concept Videos

Post-surgical recurrence of Crohn's disease: Situational analysis and future prospects.

The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases.

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.

Toxicological consequences of experimental exposure to aluminum in human intestinal epithelial cells.

Gut: An underestimated target organ for Aluminum.

Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs.

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC.

High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium.

A durably colonising engineered native symbiont enables sustained intestinal delivery for metabolic dysfunction and colitis.

Impact of non-enteric-coated pancreatic enzyme replacement therapy (NEPERT) on pain in patients with chronic pancreatitis: a double-blind, parallel-group, placebo-controlled, randomised trial.

HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infection.

Integrated Traditional Chinese and Western Medicine for Severe Tislelizumab-Induced Rash: A Case Report.

Glucocorticoids combined with rituximab treatment for IgG4-related tubulointerstitial nephritis with diabetic nephropathy: a case report.

Quality Assessment of an Immunotherapy Toxicity Clinic: A Clinical Audit at Castle Hill Hospital Evaluating Adherence to Clinical Guidelines, Documentation Standards, and Clinical Outcomes.

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

CD20 targeted nanomedicine enhances anti-tumor immunity in diffuse large B-cell lymphoma by activating cGAS/STING pathway.

Effects of anion excipients on the viscosity of high-concentration mAb solution.

Related Experiment Videos

Specific targeting of IL-6 signalling pathway: a new way to treat IBD?

Related Concept Videos

Related Articles